Niacin Extended-release Tablets 1,000 mg
Lannett is recalling Niacin Extended-release Tablets 1,000 mg due to failed dissolution specifications.
Contact your healthcare provider or pharmacist if you have questions or concerns regarding your medication. Do not stop taking your medication without consulting a medical professional.
Why it was recalled
Lannett is recalling specific lots of Niacin Extended-release Tablets due to failed dissolution specifications. The product failed to meet stability testing requirements for dissolution at the 24-hour timepoint.
Is mine affected?
Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.
Niacin Extended-release Tablets, USP, 1,000 mg, 90-count bottles, Rx Only, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136, NDC 62175-322-46.
- Recall #
- D-0584-2026
Where it was sold
Distributed nationwide.
Official source
Other recent recalls from Lannett Company Inc.
Editorial summary by Recall Canary · last updated 2026-06-11 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification